🟢 Telix Pharmaceuticals is trading 5.47% up in after-hours trading — reason remains unconfirmed

Telix Pharmaceuticals is trading 5.47% up at $11.91 after rising from the August 28 regular-session close of $11.29; the reason remains unconfirmed.

• Searches found no new company announcement dated August 28, 2026; the latest listed disclosure was the August 20 half-year results announcement.
• Recent FDA-related coverage appears stale or misdated, with no verified catalyst directly explaining the after-hours move.
• Trading activity details are unavailable; broader market conditions were mixed rather than strongly directional.